Cardiomyocytes of chronically ischemic pig hearts express the MDR-1 gene-encoded P-glycoprotein

Journal of Histochemistry and Cytochemistry

Volumn 53, Issue 7, 2005, Pages 845-850

  Lazarowski, Alberto J ^a   García Rivello, Hernán J ^b   Vera Janavel, Gustavo L ^c   Cuniberti, Luis A ^c   Cabeza Meckert, Patricia M ^c,d   Yannarelli, Gustavo G ^c   Mele, Aníbal ^e   Crottogini, Alberto J ^c   Laguens, Rubén P ^c  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^c FAVALORO UNIVERSITY   (Argentina)

^d Scientific Investigation Commission of Buenos Aires Province   (Argentina)

^e HOSPITAL UNIVERSITARIO FUNDACIÓN FAVALORO   (Argentina)

Author keywords

ATP binding cassette transporters; Cardiomyocyte; Hypoxia; MDR; Myocardial ischemia; P glycoprotein; Pig

Indexed keywords

ABC TRANSPORTER; DOBUTAMINE; GLYCOPROTEIN P; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; MULTIDRUG RESISTANCE PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAMERA; CHRONIC DISEASE; CONTROLLED STUDY; DRUG UPTAKE; HEART LEFT VENTRICLE; HEART MUSCLE CELL; HEART MUSCLE PERFUSION; HISTOPATHOLOGY; HYPOXIA; IMMUNOHISTOCHEMISTRY; ISCHEMIC HEART DISEASE; NONHUMAN; PHARMACOLOGICAL PROCEDURES; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARCOLEMMA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SWINE; WESTERN BLOTTING;

ANIMALS; ARTERIAL OCCLUSIVE DISEASES; CAROTID ARTERY DISEASES; CHRONIC DISEASE; GENES, MDR; IMMUNOHISTOCHEMISTRY; MYOCARDIAL ISCHEMIA; MYOCYTES, CARDIAC; P-GLYCOPROTEIN; SARCOLEMMA; SWINE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

ANIMALIA; SUIDAE; SUS SCROFA;

EID: 21544479109     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/jhc.4A6542.2005     Document Type: Article

References (31)

1. Beck WT (1987) The cell biology of multidrug resistance. Biochem Pharmacol 36:2879-2887
2. Bergeron M, Gidday JM, Yu AY, Semenza GL, Ferriero DM, Sharp FR (2000) Role of hypoxia-inducible factor-1 in hypoxia-induced ischemic tolerance in neonatal rat brain. Ann Neurol 48:285-296
3. Blackmore CG, McNaughton PA, van Veen HW (2001) Multidrug transporters in prokaryotic and eukaryotic cells: physiological functions and transport mechanisms. Mol Membr Biol 18:97-103
4. Bozkurt B, Kribbs SB, Clubb FJ Jr, Michael LH, Didenko VV, Hornsby PJ, Seta Y, et al. (1998) Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats. Circulation 97:1382-1391
5. Cai Z, Manalo DJ, Wei G, Rodriguez ER, Fox-Talbot K, Lu H, Zweier JL, et al. (2003) Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury. Circulation 108:79-85
6. Comerford KM, Wallace TJ, Karhausen J, Louis NA, Montalto MC, Colgan SP (2002) Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res 62:3387-3394
7. Cordon-Cardo C, O'Brien JP, Boccia J, Casals D, Bertino JR, Melamed MR (1990) Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J Histochem Cytochem 138:1277-1287
8. Crottogini A, Meckert PC, Vera Janavel G, Lascano E, Negroni J, Del Valle H, Dulbecco E, et al. (2003) Arteriogenesis induced by intramyocardial vascular endothelial growth factor 165 gene transfer in chronically ischemic pigs. Hum Gene Ther 14:1307-1318
9. Endicott JA, Ling V (1989) The biochemistry of P-glycoprotein-mediated multidrug resistance. Ann Rev Biochem 58:137-171
10. Gottesman MM, Pastan I (1988) The multidrug transporter, a double-edged sword. J Biol Chem 263:12163-12166
11. Johnstone RW, Cretney E, Smyth MJ (1999) P-glycoprotein protects leukemia cells against caspase-dependent, but not caspase-independent, cell death. Blood 93:1075-1085
12. Juliano RL, Ling V (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochem Biophys Acta 455:152-162
13. Kloner RA, Jennings RB (2001) Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 2. Circulation 104:3158-3167
14. Laguens R, Cabeza Meckert P, Vera Janavel G, De Lorenzi A, Lascano E, Negroni J, Del Valle H, et al. (2004) Cardiomyocyte hyperplasia after plasmid-mediated vascular endothelial growth factor gene transfer in pigs with chronic myocardial ischemia. J Gene Med 6:222-227
15. Litman T, Druley TE, Stein WD, Bates SE (2001) From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance. Cell Mol Life Sci 58:931-959
16. Martin C, Yu AY, Jiang BH, Davis L, Kimberly D, Hohimer AR, Semenza GL (1998) Cardiac hypertrophy in chronically anemic fetal sheep: increased vascularization is associated with increased myocardial expression of vascular endothelial growth factor and hypoxia-inducible factor 1. Am J Obstet Gynecol 178:527-534
17. Meissner K, Sperker B, Karsten C, Zu Schwabedissen HM, Seeland U, Bohm M, Bien S, et al. (2002) Expression and localization of P-glycoprotein in human heart: effects of cardiomyopathy. J Histochem Cytochem 50:1351-1356
18. Pastan I, Gottesman M (1987) Multiple-drug resistance in human cancer. N Engl J Med 316:1388-1393
19. Ramos AJ, Lazarowski A, Villar MJ, Brusco A (2004) Transient expression of MDR-1/P-glycoprotein in a model of partial cortical devascularization. Cell Mol Neurobiol 24:101-107
20. Schuetz EG, Beck WT, Schuetz JD (1996) Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells. Mol Pharmacol 49:311-318
21. Seegers U, Potschka H, Loscher W (2002) Lack of effects of prolonged treatment with phenobarbital or phenytoin on the expression of P-glycoprotein in various rat brain regions. Eur J Pharmacol 451:149-155
22. Sims JJ, Neudeck BL, Loeb JM, Wiegert NA (2004) Tachycardia-induced heart failure does not alter myocardial P-glycoprotein expression. Pharmacotherapy 24:1-7
23. Smit JJ, Schinkel AH, Mol CA, Majoor D, Mooi WJ, Jongsma AP, Lincke CR, et al. (1994) Tissue distribution of the human MDR3 P-glycoprotein. Lab Invest 71:638-649
24. Stein WD, Bates SE, Fojo T (2004) Intractable cancers: the many faces of multidrug resistance and the many targets it presents for therapeutic attack. Curr Drug Targets 5:333-346
25. Stroka DM, Burkhardt T, Desbaillets I, Wenger RH, Neil DA, Bauer C, Gassmann M, et al. (2001) HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia. FASEB J 15:2445-2453
26. Tainton KM, Smyth MJ, Jackson JT, Tanner JE, Cerruti L, Jane SM, Darcy PK, et al. (2004) Mutational analysis of P-glycoprotein: suppression of caspase activation in the absence of ATP-dependent drug efflux. Cell Death Differ 11:1028-1037
27. Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC (1987) Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA 84:7735-7738
28. Urbanek K, Quaini F, Tasca G, Torella D, Castaldo C, Nadal-Ginard B, Leri A, et al. (2003) Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy. Proc Natl Acad Sci USA 100:10440-10445
29. Zaman K, Ryu H, Hall D, O'Donovan K, Lin KI, Miller MP, Marquis JC, et al. (1999) Protection from oxidative stress-induced apoptosis in cortical neuronal cultures by iron chelators is associated with enhanced DNA binding of hypoxia-inducible factor-1 and ATF-1/CREB and increased expression of glycolytic enzymes, p21(waf1/cip1), and erythropoietin. J Neurosci 19:9821-9830.
30. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, Vinten-Johansen J (2003) Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 285: H579-588
31. [erratum: (2004) Am J Physiol Heart Circ Physiol 286: H477]